CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey ...

Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, ...

CytoSorbents Corp (NASDAQ:CTSO) shares are trading higher by 21% to $0.85 during Tuesday’s session after the company entered into a new $20 million credit facility with Avenue Capital Group. The ...

Cytosorbents Corp. Annual stock financials by MarketWatch. View the latest CTSO financial statements, income statements and financial ratios.

As of July 24, 2024, the average one-year price target for Cytosorbents is $3.70/share. The forecasts range from a low of $1.01 to a high of $6.82. The average price target represents an increase of ...

Oversubscribed Rights Offering Generated $6.25 Million in Aggregate Gross Proceeds Offering Proceeds Satisfies Debt Covenant, Unlocking $5.0 Million in Restricted Cash Currently on the Balance Sheet ...

Cytosorbents Corporation (NASDAQ:CTSO) stock has reached a notable milestone, hitting a 52-week high of $1.6, signaling a period of strong performance for the medical device company. According to ...

PRINCETON, N.J. and HYDERABAD, India, Nov. 11, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

CTSO is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of CTSO shares has decreased $0.00 since the market last closed. This is a 0.30% ...